These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 24512295)
21. Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics. Fatouh AM; Elshafeey AH; Abdelbary A Drug Des Devel Ther; 2017; 11():1815-1825. PubMed ID: 28684900 [TBL] [Abstract][Full Text] [Related]
22. Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability. Gupta S; Kesarla R; Chotai N; Misra A; Omri A Biomed Res Int; 2017; 2017():5984014. PubMed ID: 28243600 [TBL] [Abstract][Full Text] [Related]
23. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies. Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833 [TBL] [Abstract][Full Text] [Related]
25. Effects of rosmarinic acid on cognitive and biochemical alterations in ovariectomized rats treated with D-galactose. Kantar Gok D; Ozturk N; Er H; Aslan M; Demir N; Derin N; Agar A; Yargicoglu P Folia Histochem Cytobiol; 2015; 53(4):283-93. PubMed ID: 26714446 [TBL] [Abstract][Full Text] [Related]
26. Development and characterization of a novel antiacne niosomal gel of rosmarinic acid. Budhiraja A; Dhingra G Drug Deliv; 2015; 22(6):723-30. PubMed ID: 24786487 [TBL] [Abstract][Full Text] [Related]
27. Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study. El-Housiny S; Shams Eldeen MA; El-Attar YA; Salem HA; Attia D; Bendas ER; El-Nabarawi MA Drug Deliv; 2018 Nov; 25(1):78-90. PubMed ID: 29239242 [TBL] [Abstract][Full Text] [Related]
28. Optimization of artemether-loaded NLC for intranasal delivery using central composite design. Jain K; Sood S; Gowthamarajan K Drug Deliv; 2015; 22(7):940-54. PubMed ID: 24512368 [TBL] [Abstract][Full Text] [Related]
29. Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles. Castro GA; Coelho AL; Oliveira CA; Mahecha GA; Oréfice RL; Ferreira LA Int J Pharm; 2009 Oct; 381(1):77-83. PubMed ID: 19647057 [TBL] [Abstract][Full Text] [Related]
30. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency. Abd-Elal RM; Shamma RN; Rashed HM; Bendas ER Drug Deliv; 2016 Nov; 23(9):3374-3386. PubMed ID: 27128792 [TBL] [Abstract][Full Text] [Related]
31. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation. Dudhipala N; Veerabrahma K Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472 [TBL] [Abstract][Full Text] [Related]
32. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation. Nooli M; Chella N; Kulhari H; Shastri NR; Sistla R Drug Dev Ind Pharm; 2017 Apr; 43(4):611-617. PubMed ID: 28005442 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration. Manjunath K; Venkateswarlu V J Drug Target; 2006 Nov; 14(9):632-45. PubMed ID: 17090399 [TBL] [Abstract][Full Text] [Related]
34. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles. Trotta V; Pavan B; Ferraro L; Beggiato S; Traini D; Des Reis LG; Scalia S; Dalpiaz A Eur J Pharm Biopharm; 2018 Jun; 127():250-259. PubMed ID: 29486302 [TBL] [Abstract][Full Text] [Related]
35. Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery. Dhawan S; Kapil R; Singh B J Pharm Pharmacol; 2011 Mar; 63(3):342-51. PubMed ID: 21749381 [TBL] [Abstract][Full Text] [Related]
36. Chitosan-based nanoparticles for rosmarinic acid ocular delivery--In vitro tests. da Silva SB; Ferreira D; Pintado M; Sarmento B Int J Biol Macromol; 2016 Mar; 84():112-20. PubMed ID: 26645149 [TBL] [Abstract][Full Text] [Related]
37. Benzocaine loaded solid lipid nanoparticles: Formulation design, in vitro and in vivo evaluation of local anesthetic effect. Basha M; Abd El-Alim SH; Kassem AA; El Awdan S; Awad G Curr Drug Deliv; 2015; 12(6):680-92. PubMed ID: 26138680 [TBL] [Abstract][Full Text] [Related]
38. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, Patel MH; Mundada VP; Sawant KK Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488 [No Abstract] [Full Text] [Related]
39. Nose-to-brain lipid nanocarriers: An active transportation across BBB in migraine management. Kataria I; Shende P Chem Phys Lipids; 2022 Mar; 243():105177. PubMed ID: 35122739 [TBL] [Abstract][Full Text] [Related]
40. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery. Alex AT; Joseph A; Shavi G; Rao JV; Udupa N Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]